PSYG — Psyence Cashflow Statement
0.000.00%
- CA$2.58m
- CA$1.95m
- 15
- 46
- 17
- 14
Annual cashflow statement for Psyence, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 10 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11.3 | -4.6 | -6.08 | -69.4 | -0.03 |
Depreciation | |||||
Non-Cash Items | 9.17 | 0.955 | 0.406 | 64.9 | -4.94 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.117 | 0.033 | 1.94 | -0.487 | -0.584 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.2 | -3.56 | -3.64 | -4.92 | -5.55 |
Capital Expenditures | -0.376 | -0.164 | -0.264 | -0.988 | -0.014 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.004 | -0.147 | -0.166 | -0.002 | -0.002 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.373 | -0.311 | -0.43 | -0.99 | -0.015 |
Financing Cash Flow Items | — | — | -0.034 | 0 | 2.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.67 | 1.27 | 2.96 | 4.58 | 13.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.1 | -2.6 | -1.11 | -1.32 | 7.83 |